title: Impact of academic affiliation on radical cystectomy outcomes in North America: A population-based study.
abstract: BACKGROUND
  : The objective of this study was to examine the rates of blood transfusions, prolonged length of stay, intraoperative and postoperative complications, as well as in-hospital mortality, stratified according to institutional academic status in patients undergoing radical cystectomy (RC).
  
  
  METHODS
  : Within the Health Care Utilization Project Nationwide Inpatient Sample (NIS), we focused on patients in whom RC was performed between 1998 and 2007. Multivariable logistic regression analyses were fitted to predict the likelihood of blood transfusions, prolonged length of stay, intraoperative and postoperative complications, and in-hospital mortality. Covariates included age, race, gender, Charlson Comorbidity Index (CCI), hospital region, insurance status, annual hospital caseload (AHC), year of surgery and urinary diversion.
  
  
  RESULTS
  : Overall, 12 262 patients underwent RC. Of those, 7892 (64.4%) were from academic institutions. Patients treated at academic institutions were younger and healthier at baseline (all p < 0.001). RCs performed at academic institutions were associated with fewer postoperative complications (28.8% vs. 32.9%, p < 0.001), shorter length of stay (54.0% vs. 56.2%, p = 0.02) and lower in-hospital mortality rates (2.1 vs. 3.0%, p = 0.002). In multivariable analyses, patients who underwent RC at an academic hospital were 12% less likely to succumb to postoperative complications (odds ratio=0.88, p = 0.003).
  
  
  CONCLUSIONS
  : Even after adjusting for AHC, RCs performed at academic institutions are associated with better postoperative outcomes than RCs performed at non-academic institutions. From a public health prospective, performing RCs at academic institutions may help reduce costs associated with the management of complications and prolonged length of stay.
authors.affiliation: Department of Urology, Vita-Salute University, Urological Research Institute, Milan, Italy; Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Centre, Montreal, QC;
authors.forename: Marco
authors.initials: M
authors.lastname: Bianchi
authors.forename: Quoc-Dien
authors.initials: QD
authors.lastname: Trinh
authors.forename: Maxine
authors.initials: M
authors.lastname: Sun
authors.forename: Malek
authors.initials: M
authors.lastname: Meskawi
authors.forename: Jan
authors.initials: J
authors.lastname: Schmitges
authors.forename: Shahrokh F
authors.initials: SF
authors.lastname: Shariat
authors.forename: Alberto
authors.initials: A
authors.lastname: Briganti
authors.forename: Zhe
authors.initials: Z
authors.lastname: Tian
authors.forename: Claudio
authors.initials: C
authors.lastname: Jeldres
authors.forename: Shyam
authors.initials: S
authors.lastname: Sukumar
authors.forename: James O
authors.initials: JO
authors.lastname: Peabody
authors.forename: Markus
authors.initials: M
authors.lastname: Graefen
authors.forename: Paul
authors.initials: P
authors.lastname: Perrotte
authors.forename: Mani
authors.initials: M
authors.lastname: Menon
authors.forename: Francesco
authors.initials: F
authors.lastname: Montorsi
authors.forename: Pierre I
authors.initials: PI
authors.lastname: Karakiewicz